FSI
TLSIW icon

Flow State Investments’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Flow State Investments’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,162
Closed -$426 – 232
2023
Q2 		$426 Sell
10,162
-4,838
-32% -$329 ﹤0.01% 215
2023
Q1 		$921 Buy
15,000
+4,967
+50% +$438 ﹤0.01% 191
2022
Q4 		$752 Buy
+10,033
New +$680 ﹤0.01% 154

Other funds holding TLSIW

Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
MSD Partners
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Flow State Investments's TLSIW Position: Q3 2023 in Review

Flow State Investments sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2023, closing a stake of 10,162 shares — an estimated $426 sold.

Flow State Investments first reported a position in TLSIW in Q4 2022 and held it in 3 quarters. The position peaked at $921 in Q1 2023. 19 funds tracked by Wall St. Rank hold TLSIW as of Q3 2023.

  • Flow State Investments reported no remaining TriSalus Life Sciences Warrant position as of Q3 2023 after selling out during the quarter.
  • Flow State Investments sold 10,162 TriSalus Life Sciences Warrant shares in Q3 2023, an estimated $426.
  • Flow State Investments first reported a position in TriSalus Life Sciences Warrant in Q4 2022 and held it in 3 quarters.
  • Flow State Investments's TriSalus Life Sciences Warrant position peaked at $921 in Q1 2023.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2023.

Based on Flow State Investments's 13F filing for Q3 2023, filed 14 Nov 2023.